ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $663,000 | -29.8% | 16,400 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $944,000 | -1.8% | 16,400 | +8.6% | 0.00% | 0.0% |
| Q1 2015 | $961,000 | -71.6% | 15,100 | -72.4% | 0.00% | -66.7% |
| Q4 2014 | $3,383,000 | +61.6% | 54,800 | +1.7% | 0.01% | +50.0% |
| Q3 2014 | $2,093,000 | +15.1% | 53,900 | +2.1% | 0.00% | +33.3% |
| Q2 2014 | $1,819,000 | -41.0% | 52,800 | -25.9% | 0.00% | -50.0% |
| Q1 2014 | $3,081,000 | +9.2% | 71,300 | +0.7% | 0.01% | +20.0% |
| Q4 2013 | $2,821,000 | +12.0% | 70,800 | +5.5% | 0.01% | 0.0% |
| Q3 2013 | $2,519,000 | +30.2% | 67,100 | -6.8% | 0.01% | +25.0% |
| Q2 2013 | $1,935,000 | – | 72,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |